First, patient education is crucial
In reality, out-of-pocket costs for GLP-1 injectables and orals are expected to be around $350 a month or higher depending on the medication and dose
Without insurance coverage, FDA-approved brand-name GLP-1 medications can run significantly higher at retail - often $900 to $1,300+ per month without insurance - placing evidence-based pharmacotherapy out of reach for the majority of patients who could clinically benefit
Rival Eli Lillys tirzepatide, the active ingredient in Mounjaro and Zepbound, showed in a mid-stage trial that up to 74 percent of patients achieved absence of MASH with no worsening of fibrosis
Uh, for example, one in about one thousand patients aged sixty six or older with diabetes who use a GLP-1 for at least six months may develop that namd over three years, uh, compared to similar patients not on any of these medications